Literature DB >> 5543994

Myocardial infarction and deep-vein thrombosis.

A N Nicolaides, V V Kakkar, J T Renney, P H Kidner, D C Hutchison, M B Clarke.   

Abstract

In a study of 52 patients admitted into the coronary intensive care unit the incidence of deep-vein thrombosis was measured with the (125)I-fibrinogen test. Of these patients 31 were eventually confirmed to be suffering from acute myocardial infarction. This preliminary study showed that in patients with a confirmed infarct who were not treated with anticoagulants the incidence of deep-vein thrombosis was 38% and in those treated it was 5.5%. In patients who were "severely ill" from whatever the cause there was a high incidence of deep-vein thrombosis (68%).

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5543994      PMCID: PMC1795060          DOI: 10.1136/bmj.1.5746.432

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  Anticoagulants in acute myocardial infarction.

Authors:  T HILDEN; K IVERSEN; F RAASCHOU; M SCHWARTZ
Journal:  Lancet       Date:  1961-08-12       Impact factor: 79.321

2.  IN VIVO BEHAVIOR OF I-FIBRINOGEN.

Authors:  A S McFarlane
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

3.  Leg-vein thrombosis following myocardial infarction.

Authors:  T S Murray; A R Lorimer; F C Cox; T D Lawrie
Journal:  Lancet       Date:  1970-10-17       Impact factor: 79.321

4.  125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis.

Authors:  V V Kakkar; A N Nicolaides; J T Renney; J R Friend; M B Clarke
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

5.  Natural history of postoperative deep-vein thrombosis.

Authors:  V V Kakkar; C T Howe; C Flanc; M B Clarke
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

6.  125-I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography.

Authors:  D Negus; D J Pinto; L P Le Quesne; N Brown; M Chapman
Journal:  Br J Surg       Date:  1968-11       Impact factor: 6.939

7.  The detection of venous thrombosis of the legs using 125-I-labelled fibrinogen.

Authors:  C Flanc; V V Kakkar; M B Clarke
Journal:  Br J Surg       Date:  1968-10       Impact factor: 6.939

8.  Deep vein thrombosis of the leg. Is there a "high risk" group?

Authors:  V V Kakkar; C T Howe; A N Nicolaides; J T Renney; M B Clarke
Journal:  Am J Surg       Date:  1970-10       Impact factor: 2.565

9.  Detection of venous thrombosis in the legs.

Authors:  P Atkins; L A Hawkins
Journal:  Lancet       Date:  1965-12-11       Impact factor: 79.321

  9 in total
  9 in total

Review 1.  A guide to venous thromboembolism risk factor assessment.

Authors:  G D Motykie; L P Zebala; J A Caprini; C E Lee; J I Arcelus; J J Reyna; E B Cohen
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

2.  Deep venous thrombosis after myocardial infarction. Predisposing factors.

Authors:  A V Simmons; M A Sheppard; A F Cox
Journal:  Br Heart J       Date:  1973-06

3.  Venous thromboses in myocardial infarction. Comparison in heparin dosage.

Authors:  P G Habersberger; A Pitt; S T Anderson
Journal:  Br Heart J       Date:  1973-05

4.  Varicose veins, deep vein thrombosis, and haemorrhoids: epidemiology and suggested aetiology.

Authors:  D P Burkitt
Journal:  Br Med J       Date:  1972-06-03

5.  Plasma 125 I-labelled fibrinogen clearance in diagnosis of deep venous thrombosis after myocardial infarction.

Authors:  A V Simmons; M A Sheppard; A F Cox
Journal:  Br Heart J       Date:  1972-07

Review 6.  Distal deep vein thrombosis: what's the best treatment?

Authors:  L R Powers
Journal:  J Gen Intern Med       Date:  1988 May-Jun       Impact factor: 5.128

7.  Thrombosis: its role and prevention in cardiovascular events-Part II.

Authors:  L A Harker; A R Thompson; J M Harlan
Journal:  West J Med       Date:  1981-04

8.  [Autologous 131J-tagged human fibrinogen for early detection of venous thrombosis (preparation, biological and in vivo properties) (author's transl)].

Authors:  T Wuppermann; K Sippel; H Dahlgrün
Journal:  Klin Wochenschr       Date:  1978-05-01

9.  Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking.

Authors:  P A Emerson; P Marks
Journal:  Br Med J       Date:  1977-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.